P
US8129148B2ExpiredUtilityPatentIndex 35

Process for preparation of chondroitin fraction

Assignee: SUGIURA NOBUOPriority: Aug 24, 2005Filed: Aug 23, 2006Granted: Mar 6, 2012
Est. expiryAug 24, 2025(expired)· nominal 20-yr term from priority
Inventors:SUGIURA NOBUOKIMATA KOJI
C12P 19/26
35
PatentIndex Score
0
Cited by
11
References
2
Claims

Abstract

Provided are a method for producing a fraction containing more than 50% of CH represented by the general formula (1), which comprises at least the step of allowing a glucuronic acid donor, an N-acetylgalactosamine donor, a saccharide acceptor, a chondroitin polymerase derived from the Escherichia coli K4 strain, and Mn2+ at a final concentration of 0.02 to 100 mM to coexist, and performing a reaction thereof under conditions of 20 to 40° C. and pH 6 to 8 for 0.5 minutes to 4 hours, and a method for producing a fraction containing more than 50% of CH represented by the general formula (2), which comprises at least the step of performing the reaction under same conditions for 10 hours or longer, which enable industrial scale production of a CH fraction of a controlled even number saccharide and odd number saccharide content ratio by a simple procedure at a low cost. (GlcA-GalNAc)n  (1) GalNAc-(GlcA-GalNAc)n  (2) (In the formula, GlcA represents a glucuronic acid residue, GaINCAc represents a N-acetylgalactosamine residue, - represents a glycosidic bond, and n represents an arbitrary integer.)

Claims

exact text as granted — not AI-modified
What is claimed is: 
     
       1. A method for producing a fraction comprising more than 50% of chondroitin represented formula (1), comprising the steps:
 (a) reacting a glucuronic acid donor, a N-acetylgalactosamine donor, a saccharide acceptor, chondroitin polymerase derived from  Escherichia coli  K4, and Mn 2+  at a final concentration of 0.02 to 100 mM at 30° C. and pH 7.2 for 5 hours and measuring a chondroitin content ratio, X, in a fraction produced by the reaction, wherein the chondroitin content ratio, X, means a ratio of a number of chondroitin molecules represented by formula (1)/a number of chondroitin molecules represented by formula (2); 
 (b) determining a reaction time for providing the chondroitin content ratio, X, as determined in step (a) in a fraction produced when the reaction is performed under conditions of arbitrary temperature and pH, other than at 30° C. and pH 7.2, at which the chondroitin polymerase derived from  Escherichia coli  K4 can act for a reaction time defined to be Y; and 
 (c) performing the reaction at the same temperature and pH as step (b) for a time shorter than Y, 
 wherein formulae (1) and (2) are:
   (GlcA-GalNAc) n   (1)
 
   GalNAc-(GlcA-GalNAc) n   (2)
 
 
 wherein GlcA represents a glucuronic acid residue, GalNac represents an N-acetylgalactosamine residue, - represents a glycosidic bond and n represents an arbitrary integer. 
 
     
     
       2. A method for producing a fraction comprising more than 50% of chondroitin represented by formula (2), comprising the steps of:
 (a) reacting a glucuronic acid donor, a N-acetylgalactosamine donor, a saccharide acceptor, chondroitin polymerase derived from  Escherichia coli  K4, and Mn 2+  at a final concentration of 5 to 100 mM at 30° C. and pH 7.2 for 8 hours and measuring a chondroitin content ratio, X, in a fraction produced by the reaction, wherein the chondroitin content ratio, X, means a ratio of a number of chondroitin molecules represented by formula (1)/a number of chondroitin molecules represented by formula (2); 
 (b) determining a reaction time for providing the chondroitin content ratio, X, as determined in step (a) in a fraction produced when the reaction is performed under conditions of arbitrary temperature and pH , other than at 30° C. and pH 7.2, at which the chondroitin polymerase derived from  Escherichia coli  K4 can act for a reaction time defined to be Y; and 
 (c) performing the reaction at the same temperature and pH as step (b) for a time longer than Y, 
 wherein formulae (1) and (2) are:
   (GlcA-GalNAc) n   (1)
 
   GalNAc-(GlcA-GalNAc) n   (2)
 
 
 wherein, GlcA represents a glucuronic acid residue, GalNAc represents an N-acetylgalactosamine residue, - represents a glycosidic bond, and n represents an arbitrary integer.

Cited by (0)

No later patents cite this yet.

References (0)

No backward citations on record.